CLOV CLOVER HEALTH INV CORP

Clover Health Announces Planned Medicare Advantage Expansion for 2023

Clover Health Announces Planned Medicare Advantage Expansion for 2023

FRANKLIN, Tenn., July 14, 2022 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced its intent to offer Medicare Advantage (“MA”) plans in 13 new counties across Georgia, South Carolina, and Tennessee.

Subject to approval from the Centers for Medicare and Medicaid Services (“CMS”), individuals eligible for Medicare in these new counties will be able to sign up for Clover’s MA plans during the MA Annual Enrollment Period (“AEP”), which runs from October 15 to December 7, with coverage starting on January 1, 2023.

Clover currently offers its MA plans in 209 counties where it cares for approximately 85,000 members. Clover’s planned expansion will make its MA plans available in 220 counties across eight states: Alabama, Georgia, Mississippi, New Jersey, Pennsylvania, South Carolina, Tennessee, and Texas. As part of its focus on sustainable membership growth, Clover will be exiting two of its smaller markets, the counties of El Paso, Texas, and Pima, Arizona.

“We are aiming to generate industry-leading growth during this year’s AEP, as we have over the past several years, and we’re focusing our efforts on our existing footprint where we have a proven track record,” said Andrew Toy, President of Clover. “Clover Assistant is designed to lower costs and improve outcomes, and this year’s bids demonstrate our continued focus on passing savings back to our members in the form of great benefits at affordable prices.”

In Georgia, Clover is aiming to replicate a successful growth strategy honed in New Jersey. In 2022, Clover nearly tripled its membership in Georgia by significantly increasing the breadth and depth of its provider network throughout the state with the addition of dozens of hospitals, health systems and key provider partners across the region, aligning approximately 5,000 new primary care physicians and specialists with Clover’s MA network. In 2023, subject to CMS approval, Clover plans will be available to eligible individuals in 151 of the 159 counties in Georgia, which together contain a market opportunity of nearly 650,000 Medicare eligibles.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is underpinned by our proprietary software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO plans to Medicare Advantage members in several states. Our Non-Insurance line of business offers a variety of programs aimed at reducing expenditures and enhancing the quality of care for patients enrolled in fee-for-service Medicare. Clover’s corporate headquarters are in Franklin, Tenn.

Cautionary Statement About Forward-Looking Statements

This news release contains forward-looking statements about our future growth, financial performance and business. Because forward-looking statements are based on our current expectations and assumptions regarding the future, they are subject to inherent risks and uncertainties. You are urged not to unduly rely on forward-looking statements, as actual results could differ materially from expectations. Forward-looking statements speak only as of the date made, and we do not undertake to update them to reflect changes or events that occur after that date. For information about factors that could cause actual results to differ materially from our expectations, refer to our reports filed with the Securities and Exchange Commission (the “SEC”), including the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021, available on the SEC’s website at , and in our other reports filed with the SEC.

Visit:

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



Steve Halper



EN
14/07/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Launches New Clinical Program in Partnership with Quarte...

Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover’s home-based care model FRANKLIN, Tenn., March 19, 2024 (GLOBE NEWSWIRE) -- Today, (“Clover” or the “Company”) announced a partnership with a value-based behavioral health care enablement and delivery company, to increase the support and resources provided to Clover members with serious mental illness (SMI) through the Company’s home-based care delive...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: March 18, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Resu...

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance Full-year 2023 Insurance MCR improved to 81.2% and fourth quarter MCR to 82.4% Company improves full-year 2023 Net Loss by $126.2 million and full-year Adjusted EBITDA by $245.7 million year-over-year Issues 2024 guidance with Insurance MCR range of 79% - 83% and up to $20 million of Adjusted EBITDA profitability at the high end of the range FRANKLIN, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp...

 PRESS RELEASE

Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare ...

Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage Mr. Thornton brings a decade of Medicare Advantage leadership experience FRANKLIN, Tenn., March 07, 2024 (GLOBE NEWSWIRE) -- Today Clover Health ("Clover" or "the Company") announced Clay Thornton as the newly appointed Chief Financial Officer of its Medicare Advantage (MA) division. Thornton, with an impressive track record spanning over a decade of healthcare financial management and operational leadership, joins as the Company enters the next phase of its lifecycle, targeting Adjusted EBITDA profitability...

 PRESS RELEASE

Clover Health to Report Fourth Quarter and Full Year 2023 Financial Re...

Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter and full year 2023 financial results after market close on Tuesday, March 12, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on March 12, 2024 to discuss the Company’s business and financial results. Fourth Quarter and Full Year 2023 Conference Call and Webcast Detail...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch